NCT00778284View on ClinicalTrials.gov

Bioequivalence Study of Amoxicillin 400 mg/Clavulanic Acid 57 mg Chewable Tablets Under Fed Conditions

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

October 31, 2002

Study Completion Date

December 31, 2002

Conditions
Healthy
Interventions
DRUG

Amoxicillin 400mg + clovalunic acid 57.5mg chewable tablets

Trial Locations (1)

85044

MDS Pharma Services, Phoenix

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00778284 - Bioequivalence Study of Amoxicillin 400 mg/Clavulanic Acid 57 mg Chewable Tablets Under Fed Conditions | Biotech Hunter | Biotech Hunter